UAS
TMO icon

United Asset Strategies’s Thermo Fisher Scientific TMO Stock Holding History

United Asset Strategies’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
31,417
+322
+1% +$155K 1.11% 24
2026
Q1 		$15.3M Sell
31,095
-546
-2% -$296K 1.22% 24
2025
Q4 		$18.3M Sell
31,641
-520
-2% -$294K 1.42% 17
2025
Q3 		$15.6M Buy
32,161
+5,950
+23% +$2.77M 1.25% 24
2025
Q2 		$10.6M Sell
26,211
-10,128
-28% -$4.23M 0.91% 39
2025
Q1 		$18.1M Buy
36,339
+9,070
+33% +$4.91M 1.68% 10
2024
Q4 		$14.2M Buy
27,269
+1,118
+4% +$615K 1.3% 22
2024
Q3 		$16.2M Buy
26,151
+950
+4% +$562K 1.51% 17
2024
Q2 		$13.9M Buy
25,201
+768
+3% +$440K 1.38% 23
2024
Q1 		$14.2M Buy
24,433
+1,150
+5% +$645K 1.42% 19
2023
Q4 		$12.4M Buy
23,283
+1,033
+5% +$500K 1.39% 22
2023
Q3 		$11.3M Buy
22,250
+287
+1% +$153K 1.46% 18
2023
Q2 		$11.5M Buy
21,963
+303
+1% +$164K 1.43% 19
2023
Q1 		$12.5M Buy
21,660
+220
+1% +$124K 1.65% 17
2022
Q4 		$11.8M Buy
21,440
+137
+0.6% +$72.6K 1.65% 17
2022
Q3 		$10.8M Buy
21,303
+53
+0.2% +$29.7K 1.66% 15
2022
Q2 		$11.5M Buy
21,250
+1,719
+9% +$946K 1.68% 18
2022
Q1 		$11.5M Sell
19,531
-1,643
-8% -$944K 1.47% 19
2021
Q4 		$14.1M Sell
21,174
-395
-2% -$247K 1.68% 16
2021
Q3 		$12.3M Buy
21,569
+282
+1% +$155K 1.59% 20
2021
Q2 		$10.7M Buy
21,287
+292
+1% +$138K 1.43% 25
2021
Q1 		$9.58M Buy
20,995
+2,221
+12% +$1.06M 1.39% 27
2020
Q4 		$8.74M Buy
18,774
+274
+1% +$128K 1.37% 25
2020
Q3 		$8.17M Sell
18,500
-568
-3% -$235K 1.5% 23
2020
Q2 		$6.91M Buy
19,068
+304
+2% +$102K 1.36% 23
2020
Q1 		$5.32M Buy
+18,764
New +$5.92M 1.32% 26

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

United Asset Strategies's TMO Position: Q2 2026 in Review

United Asset Strategies increased its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, buying an estimated $155K and bringing the position to 31,417 shares worth $15.8M. The position accounts for 1.11% of the portfolio, ranked #24.

United Asset Strategies first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $18.3M in Q4 2025. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • United Asset Strategies held 31,417 shares of Thermo Fisher Scientific worth $15.8M as of Q2 2026.
  • United Asset Strategies bought 322 Thermo Fisher Scientific shares in Q2 2026, an estimated $155K.
  • Thermo Fisher Scientific made up 1.11% of United Asset Strategies's portfolio in Q2 2026, its #24 holding.
  • United Asset Strategies first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
  • United Asset Strategies's Thermo Fisher Scientific position peaked at $18.3M in Q4 2025.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on United Asset Strategies's 13F filing for Q2 2026, filed 13 Jul 2026.